Knowledge

Cross-Border Pharmaceutical Sourcing: A Practical Compliance Playbook for Aesthetic Clinics

Posted on by admin5

Cross-border sourcing of pharmaceuticals and related medical products can safely support aesthetic clinic growth, but only when expiration rotation, temperature control, and distribution authorization are treated as hard regulatory requirements, not logistics “extras.” For clinic owners and medspa operators, the decision is not simply whether a product is cheaper abroad, but whether every lot can be legally tracked, temperature-verified, correctly labeled, and supported by a compliant wholesale supply chain in your jurisdiction. This article outlines a decision-grade framework for working with vetted trading partners like ALLWILL to manage lot integrity, distribution rights, and documentation so you can request quotes confidently, rather than gambling on gray-market channels.

What cross-border sourcing actually covers – and who it is for

For aesthetic clinics, “cross-border pharmaceutical sourcing” typically involves neuromodulators, dermal fillers, topical anesthetics, skin boosters, and support medications such as emergency adrenaline, antihistamines, and antibiotics procured through foreign wholesalers or regional distributors. It may also touch single-use medical devices, injectables, and combination products bundled with aesthetic platforms, which sit at the intersection of medicinal product and medical device regulations.

This model suits mid-to-high volume clinics, multi-site medspa groups, and hospital-based dermatology units that need consistent access to specific brands, presentations, or dose forms that are intermittently unavailable locally or priced at a premium. It is not appropriate for early-stage clinics without a formal quality system, because regulators increasingly treat importers, distributors, and even clinic purchasers as part of the regulated supply chain with explicit obligations around storage, documentation, and complaint handling.

ALLWILL primarily supports this segment where capital equipment, injectables, and accessories move together, helping align medical device sourcing with pharmaceutical and consumable flows so clinics do not manage compliance in silos.

Topic-specific core analysis: tracking, temperature, and distribution authorization

Because this topic centers on logistics, sourcing, and vendor verification, the core analysis must focus on three pillars: legal authority to distribute, verifiable product history, and preserved product quality under Good Distribution Practice (GDP) conditions.

1. Distribution authorization and legal roles

Most jurisdictions treat foreign manufacturers, importers, and wholesale distributors as regulated “establishments” that must hold licenses or registrations and meet GDP or equivalent standards. In the EU, the Medical Device Regulation and medicinal product directives assign specific obligations to manufacturers, authorized representatives, importers, and distributors, making it clear who is accountable if a product is mislabeled, counterfeit, or improperly stored. In Canada and many other markets, any entity that fabricates, packages, labels, imports, distributes, or tests drugs must hold an establishment license, and clinics are expected to verify that their suppliers are appropriately licensed.

For aesthetic clinics buying cross-border, this means you should be able to see, upon request, the supplier’s wholesale distribution license, proof of manufacturer authorization to distribute the relevant product in your region, and written confirmation that export and import are allowed under that product’s marketing authorization. ALLWILL’s role is to sit on the compliant side of this chain by partnering only with distributors and logistics providers who can document their establishment licenses, GDP certifications, and manufacturer agreements, and by keeping those documents on file for due diligence requests.

2. Lot-level traceability and serialization

Regulators expect pharmaceutical lot traceability from manufacturer to patient, and many markets now require serial numbers and tamper-evident features to combat falsified medicines. Distributors must keep distribution records that can reconstruct to whom each batch was supplied, and clinics are expected to record lot numbers and expiration dates in patient charts for recall and pharmacovigilance purposes.

A compliant cross-border supply chain therefore needs:

  • Lot numbers and expiration dates captured at every transfer.
  • Inbound inspections at the clinic to confirm lot/expiry against packing list.
  • Systems to reconcile recalls and quarantines quickly if the manufacturer or authority issues an alert.

ALLWILL aligns device and pharmaceutical flows by ensuring that capital equipment, consumables, and emergency medications moving through its trading platform can be documented at lot level with packing lists, serials, and expiration data, supporting clinics’ internal records and recall workflows.

3. Temperature-controlled asset preservation

Temperature deviations during international transport can compromise neuromodulators, biologics, and some anesthetics, even if vials look intact. Good Distribution Practice frameworks require validated cold chain packaging, temperature-monitored transport, and records demonstrating that each shipment stayed within the specified range throughout shipping and interim storage.

Also check:  Navigating Refurbished Medical Devices Market in Asia: Logistics, Compliance, Quality

This is where many low-cost channels fail: products may technically be genuine but arrive with no evidence of compliant temperature management or without any indication that the logistics provider is audited against GDP or equivalent standards. For aesthetic clinics, the risk is not only loss of product integrity but also regulatory exposure if an adverse event is later linked to compromised storage.

By working with GDP-aware logistics partners and using data loggers or validated packaging, ALLWILL helps clinics obtain documentation of temperature control and chain-of-custody for critical temperature-sensitive products, integrating those data into shipment records so clinical and purchasing teams can retain proof for audits.

Revenue and operational impact: where compliant sourcing pays off

Aesthetic clinic owners often approach cross-border sourcing for price relief, but the economics are more nuanced once you factor in wastage, stockouts, and compliance risk.

On the savings side, clinics may see lower acquisition costs by purchasing from regions with different pricing structures or promotional cycles, especially for high-volume injectables. However, any savings are quickly eroded if large lots expire unused due to poor inventory rotation, shipments are rejected over labeling discrepancies, or regulators require destruction of non-compliant stock.

The operational upside of working with a compliant partner like ALLWILL is that lot-level tracking, expiration management, and verified distribution rights reduce the probability of forced write-offs, emergency last-minute purchases, or reputational damage from recalls that cannot be traced properly. In practice, this means:

  • More predictable cost per treatment, because fewer units are lost to expiration or temperature doubt.
  • Less unplanned downtime from product unavailability or regulatory holds.
  • Better negotiating position with payers or corporate partners due to robust documentation and audit readiness.

Request a quote from ALLWILL for a current price and compliance-verified sourcing plan that aligns with your clinic’s volume, storage capacity, and regulatory environment.

Differentiated advantage: why high-trust sourcing is worth a premium

Not all discounts are equal when patient safety, brand reputation, and regulatory relationships are at stake. A very low unit price from an unverified reseller may mask exposure to falsified products, misbranded imports, or incomplete labeling that fails to meet local language or content rules, any of which can lead to enforcement actions or civil liability.

High-trust sourcing emphasizes:

  • Products with clear legal routes into your market.
  • Suppliers with documented distribution authorization and GDP-compliant handling.
  • Integrated documentation (lot, expiry, temperature, and labeling) ready for audit.

ALLWILL supports this higher-trust model by combining device sourcing, pharmaceutical and consumable procurement, and digital asset management in its Smart Center, enabling clinics to treat cross-border purchasing as an extension of their quality management system rather than a parallel, opaque workflow. The result is a more resilient supply chain that supports premium positioning and long-term patient trust.

Supplier Vetting Framework: a practical B2B decision aid

To help clinic owners and procurement leads assess potential cross-border suppliers, the following Supplier Vetting Framework table can be used during due diligence or RFP processes. It focuses on the critical dimensions: legal authorization, GDP/temperature control, lot traceability, labeling, emergency stock, and documentation readiness.

Vetting Dimension What to Verify in Writing Acceptable Examples (Illustrative) Red Flags to Watch For
Legal status & licensing Valid wholesale distribution/establishment license; registration with relevant health authority; corporate identity and physical address EU wholesale distribution authorization, Health Canada establishment license, or equivalent in exporting region “Broker only” with no license, PO boxes only, refusal to share license copies
Manufacturer authorization Letter or contract showing supplier is authorized to distribute the specific product in the origin market and for export where applicable Authorized distributor letter, manufacturer-confirmed partner listing Vague claims of “factory direct” with no documentation, brand names missing from contracts
Regulatory pathway & marketing authorization Confirmation that the product has an approved marketing authorization where required, plus indication of status in destination market (e.g., prescription-only) Reference to EU marketing authorization, FDA approval/clearance where applicable, or national authorization numbers Products labeled “for export only” with unclear legal status in your country, no MA number where one is normally required
Good Distribution Practice / quality system Evidence of GDP certification or equivalent QMS; audit schedule; handling SOPs for temperature excursions and returns GDP certificate, ISO 13485 or ISO 9001 for relevant operations, internal audit summaries made available under NDA No mention of GDP, inability to describe temperature excursion process, no quality manager identified
Cold chain & temperature monitoring Validated packaging specs, transport modes, and temperature monitoring approach; example of temperature reports Use of validated cold boxes, data loggers with downloadable reports per shipment, documented temperature mapping “Standard courier” only, no temperature monitoring, no record of packaging validation
Lot traceability & recall process Sample packing list showing batch/lot and expiry; recall SOP; contact points for urgent safety alerts Packing lists including batch and expiry, written recall action plan and timelines, 24/7 recall contact Only invoice-level detail with no lot data, no recall procedure, no records retention policy
Labeling & professional information Sample labels and professional leaflets in destination language(s); confirmation of compliance with local labeling requirements for drugs/devices Multilingual labeling with local language, correct dosage and safety information, professional package inserts Foreign-language-only labeling where local language is mandatory, missing safety warnings, handwritten modifications
Emergency/critical stock policy Supplier’s minimum stock levels, replenishment lead times, and contingency suppliers for critical molecules or SKUs Defined safety stock levels, ability to hold dedicated stock for your clinic or group, transparent lead times No stock visibility, “we order when you order,” highly variable lead times with no communication
Documentation pack for audits Standard documentation pack provided with shipments or on demand: licenses, certificates, COAs, temperature logs, contracts Bundled digital documentation per shipment; secure portal access to historical records “We don’t normally share that,” fragmented or missing historical records
Also check:  Aesthetic Laser Devices: Mastering Flawless Results, Efficiency, and Trusted Technology

Clinics can adapt this framework into their internal SOPs, using it to score suppliers and to document the rationale for selecting partners like ALLWILL that can satisfy most or all criteria consistently.

Request a quote from ALLWILL to obtain a sample documentation pack and to benchmark current suppliers against a fully vetted, compliance-focused alternative.

Compliance and asset protection: aligning with regulators

Internationally, regulators are tightening oversight of both medical devices and medicinal products, aligning quality expectations around standards such as ISO 13485 and GDP. This means that even if your clinic is not formally licensed as a wholesaler, authorities increasingly expect you to be able to demonstrate that your upstream supply chain is licensed, traceable, and documented.

Clinics should therefore treat cross-border sourcing as part of their quality management system:

  • Maintain a supplier approval list with vetting records.
  • File copies of supplier licenses, GDP certificates, and manufacturer authorizations.
  • Store shipment-level records including packing lists, temperature reports for cold-chain shipments, and any certificates of analysis.

ALLWILL can support these asset-protection measures by integrating device and pharmaceutical documentation in a single record set, making it easier for clinics to respond to audits, insurance reviews, or risk assessments. It is still essential for clinics to verify the current regulatory status of each product in their own region, as approvals, indications, and labeling rules can change over time and differ between markets.

Procurement risks to avoid – and an ALLWILL expert view

The main procurement risks in cross-border pharmaceutical sourcing for aesthetic clinics fall into four categories: authenticity and falsified products, regulatory misalignment, supply instability, and documentation gaps.

  • Authenticity risk arises when price, packaging, and channel do not match expected patterns, especially for high-value injectables that are frequent targets of counterfeiters.
  • Regulatory misalignment occurs when a product is lawfully sold in one country but does not have a valid route into your country, or labeling does not meet local language or content requirements.
  • Supply instability tends to follow overly opportunistic buying from one-off brokers without long-term contracts, leading to volatile pricing, stockouts, or inconsistent batch quality.
  • Documentation gaps become acutely visible during recalls, audits, or adverse event investigations, when clinics cannot produce lot details, temperature logs, or supplier authorizations.

ALLWILL Expert View: Designing a defensible cross-border play

From a procurement and asset-protection perspective, the most sustainable cross-border sourcing strategy is built on documentation, not discount percentages. Clinics that treat every shipment like a potential audit exhibit keep their risk profile low even when sourcing across borders: they insist on seeing establishment licenses, manufacturer authorization letters, GDP evidence, and product-specific marketing authorizations upfront, and they store those documents in an organized, retrievable way. Rather than chasing the lowest spot price, they negotiate structured agreements with vetted partners who can hold or allocate stock, provide temperature logs, and support recall drills, making supply and compliance more predictable. When ALLWILL works with clinics on this model, the conversation often shifts from “Can you get this cheaper abroad?” to “Can you design a supply chain where no pallet, lot, or vial is ever unaccounted for?”

Clinics considering new suppliers should ask for a trial period under a tightly controlled documentation and temperature-monitoring protocol, comparing performance against existing channels before fully shifting volumes. This allows procurement leaders to validate promises around lead times, packaging, and documentation in real-world conditions.

Also check:  How Data-Driven Medical Device Inspection and Testing Transform Healthcare Equipment Reliability

Request a quote from ALLWILL if you would like to structure such a trial, including a sample of the temperature and lot-traceability documentation you would receive per shipment.

Frequently Asked Questions

How much can cross-border sourcing realistically reduce our pharmaceutical spend?

Savings vary widely, but many aesthetic clinics see modest to moderate acquisition-cost reductions once compliant logistics, insurance, and documentation are factored in. Deep discounts that compromise labeling, storage, or traceability should be treated as high risk rather than “found money.” A tailored analysis using your procedure volumes and product mix is essential, so consider requesting a quote and scenario review with ALLWILL.

Is it legal for my clinic to import aesthetics-related pharmaceuticals directly?

Legality depends on your jurisdiction, product type, and whether the clinic holds the necessary import or establishment licenses. In many markets, clinics must purchase through licensed wholesalers or importers who hold distribution authorization, rather than importing directly as end users. Always check with your national regulator or legal advisor, and ensure any partner such as ALLWILL can document its own licensing and distribution rights.

How should we manage expiration rotations and stock levels for cross-border products?

Clinics should maintain a formal inventory management process, including first-expiry-first-out rotation, minimum and maximum stock levels, and regular reconciliation between physical counts and electronic records. For international sourcing, factor in longer lead times and customs variability when setting reorder points, and avoid over-ordering to the point where expiration risk increases. Requesting a quote that includes proposed order cycles and safety stock recommendations from ALLWILL can help align sourcing with your usage patterns.

What documentation should we demand with each cross-border shipment?

At a minimum, require a detailed packing list with batch/lot numbers and expiration dates, invoices, supplier license references, and temperature logs for cold-chain items. Many clinics also request certificates of analysis and copies of GDP or QMS certifications for new suppliers. Partners like ALLWILL can standardize this documentation into a repeatable packet for every shipment, simplifying audit readiness.

How can we verify that products and suppliers meet our local regulatory requirements?

Begin with your national regulator’s guidance on marketing authorizations, import rules, and distribution requirements for medicinal products and medical devices. Cross-check supplier licenses and product authorizations against official databases where available, and seek written confirmation from suppliers regarding their regulatory status and authorized roles. For high-risk or high-volume products, consider an external regulatory or legal review, and ask ALLWILL to share its own compliance documentation as part of your due diligence.

References

  1. Guidance on medical device compliance and enforcement (GUI-0073)

  2. WHO Good distribution practices for pharmaceutical products

  3. Guide for Distributors of Medical Devices (HPRA)

  4. Overview of Device Regulation – U.S. FDA

  5. Authorised Representatives, Importers and Distributors – European Commission

  6. Guidance on medical device establishment licensing (GUI-0016)

  7. Good distribution practices for medical devices – FAMHP draft guidance

  8. Requirements for Medical Devices Marketing Authorization – SFDA

  9. Establishment licences for drugs, medical devices and other health products – Health Canada

admin5

联系我们|Contact Form

TERMS AND CONDITIONS 

These Terms and Conditions (these “Terms”), together with the attached or accompanying quote page (the “Quote,” collectively, this “Agreement”), exclusively govern the sale by Healthcare Markets, Inc., a Delaware corporation doing business as “Powered by MRP” (“MRP”), and the purchase and use by the buyer set forth on the Quote (“Buyer”), of the equipment (the“Equipment”) and/or services (the “Services”).

        1.  EQUIPMENT AVAILABILITY. Equipment offered for sale by MRP is subject to availability. MRP shall not be liable to Buyer in case of stock outage or unavailability of the Equipment. MRP reserves the right to change the equipment offered for sale at any time and without notice to Buyer. Availability of equipment may be determined when an order is placed, and, if unavailable, MRP will inform Buyer of such unavailability, offer other available equipment as substitution or cancel the order. Such cancelled order will be refunded by MRP to Buyer, except for an order for a Special Order Product, which cannot be cancelled once the order is placed.

        2.  PRICES. Written price quotations on the Quote shall last for ten (10) days from the date issued and then automatically expire, and quoted prices do not include taxes, freight, handling, duty, insurance or other similar charges, which Buyer must pay unless waived in writing by MRP or a valid tax exemption certificate is provided to MRP. Notwithstanding the foregoing, all published prices may be changed by MRP at any time without notice to Buyer.

        3.  TERMS OF PAYMENT. Unless otherwise agreed to on the Quote or in writing by MRP, prepayment in full is required, by bank transfer, cash, credit card or certified check, and where partial pre-payment is permitted, such payment shall be nonrefundable with the balance due net thirty (30) days from the date of invoice. MRP reserves the right to modify or revoke any credit previously extended. Past due balances shall be subject to a service charge of one and one-half percent (1.5%) per month, not to exceed the maximum amount permitted by applicable law. Buyer agrees to pay all fees, charges or other sums payable hereunder, including collection fees incurred, with no right of set-off or reduction of any nature unless approved in writing by an MRP corporate officer (an “MRP Officer”). Buyer hereby grants, and MRP reserves, a purchase money security interest in the Equipment purchased, and in any proceeds thereof, to secure Buyer’s payment obligations hereunder. Buyer shall cooperate fully with MRP to execute such documents and accomplish such filings and/or recordings as MRP may deem necessary for the protection of its interests in the Equipment furnished to Buyer, and in the event Buyer does not aid within a reasonable time after MRP asks Buyer to do so, Buyer hereby authorizes and appoints MRP as Buyer’s attorney-in-fact to execute, deliver and file at any time, any financing statement and/or take any other action permitted by applicable law to perfect, enforce, continue and amend MRP’s security interest in any jurisdiction deemed appropriate by MRP. Buyer agrees that upon nonpayment of any charges due to MRP, MRP may cancel or delay delivery of the Equipment and/or suspend any applicable service coverage, which may resume only when MRP receives payment in full, and the warranty period will continue to run during such time of nonpayment although warranty service will not be available.

        4.  SHIPMENT AND DELIVERY. Delivery dates are estimated, and partial deliveries are allowed. MRP shall not be liable for or in respect of any loss or damage arising from any delay in filling any order, failure to deliver or delay in delivery. No delay in the shipment or delivery of any Equipment relieves Buyer of its obligations under this Agreement, including, without limitation, accepting delivery of any remaining installment(s) of the Equipment, if applicable. Buyer must pay for, and hold MRP harmless from, all shipping, delivery, and insurance expenses unless otherwise agreed in writing by an MRP Officer or otherwise indicated on the Quote. MRP will not assume any liability if MRP selects the shipping methods nor will any carrier be deemed to be MRP’s agent. “Time is of the essence” terms will not apply to orders accepted by MRP. Title and risk of loss of the Equipment shall pass to Buyer, and delivery shall be deemed completed, when the Equipment is delivered to Buyer’s address. Should loss or damage in transit occur, Buyer’s payment obligations will not be affected. Buyer is liable for all costs for MRP’s holding or storing of the Equipment if delivery is delayed by Buyer or at Buyer’s request. If delivery is delayed over thirty (30) days, MRP may, at its option and upon notice to Buyer, cancel that and all future deliveries without further liability or obligation of any kind.

        5.  FORCE MAJEURE. MRP shall not be responsible for delays or failure to render or service any Equipment and/or perform any Service due to any cause beyond MRP’s control, including, but not limited to: (a) acts of God; (b) flood, fire, earthquake, epidemic, pandemic or explosion; (c) war, invasion, hostilities (whether war is declared or not), terrorist threats or act, riot or other civil unrest; (d) government order, law or actions; (e) embargoes or blockades in effect on or after the date of this Agreement; (f) national or regional emergency; (g) strikes, labor stoppages or slowdowns or other industrial disturbances; and (h) telecommunication breakdowns, power outages or shortages, lack of warehouse or storage space, inadequate transportation services or inability or delay in obtaining supplies of adequate or suitable material (each, a “Force Majeure Event”). Any delivery date may be extended, at MRP’s sole discretion, to the extent of any delay resulting from any Force Majeure Event.

        6.  ACCEPTANCE; INSPECTION. Except for Special Order Products, Buyer shall inspect all Equipment upon delivery and within forty-eight (48) hours of delivery to Buyer shall give written notice to MRP of any error or claim that any Equipment does not conform to the terms of this Agreement; any claims not made within such period shall be deemed waived and released, with the Equipment being accepted by Buyer. Except as provided under this Section 6 and Section 7 hereof, all sales of Equipment to Buyer are made on a one-way basis, and Buyer has no right to return Equipment purchased under this Agreement to MRP. Subject to the warranty set forth in Section 8(c)(iv), Services are deemed to be accepted by Buyer upon completion of their performance by MRP.

        7.  CANCELLATION CHARGES AND RETURNED EQUIPMENT POLICY. Returns and cancellations are not permitted without written approval by an MRP Officer, which shall be made in such MRP Officer’s sole discretion. If approved, MRP will issue a return merchandise authorization number, which Buyer must include in the returned packaging, and Buyer must pay MRP either a (a) twenty percent (20%) restocking charge on the purchase price of the item if Buyer’s written request for return or cancellation is received by MRP’s headquarters after MRP’s original shipment of the Equipment or (b) a ten percent (10%) cancellation damages charge if Buyer’s request was received before said shipment. The foregoing charges are agreed upon, not as a penalty, but because of the difficulty of computing actual damages, and until the applicable charge is paid and the Equipment has been received back by MRP in new condition, no refund will be given. This document or copies hereof may be filed with the appropriate authorities as a financing statement to pursue such charges. In no case will shipping and freight costs be refunded. Removed, replaced or substituted equipment and parts (collectively, “Returned Equipment”) shall become MRP’s property, with title and ownership transferring to MRP upon the earlier of its return or replacement, with MRP owing no other obligations on the Returned Equipment. Buyer hereby agrees to indemnify, defend and hold harmless MRP Indemnitees from any claims, costs, losses, attorneys’ fees and expenses related to any third-party attempts to claim ownership of the Returned Equipment or dispute any trade-in, removal, substitution or replacement, and the remaining provisions shall continue in full force and effect.

        8.  MRP’S WARRANTIES, IF ANY.

(a) Equipment Sold “As Is.” UNLESS OTHERWISE STATED ON THE QUOTE OR IN A WRITING SIGNED BY AN MRP OFFICER, BUYER AGREES THAT THE EQUIPMENT SOLD IN THIS AGREEMENT IS BEING SOLD ON AN “AS IS,” “AS AVAILABLE” BASIS, SUBJECT TO SECTIONS 8(c) AND 9, AND HAVE NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, WHETHER IMPLIED OR ARISING BY LAW, STATUTE OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT, WORKMANLIKE MANNER, QUALITY, ACCURACY, TITLE, AND/OR IMPLIED FROM A COURSE OF DEALING OR PERFORMANCE USAGE IN TRADE.

(b) Special Order Product. If this Agreement includes the sale of a product that MRP does not currently have or typically keep in stock, in MRP’s sole determination, but is acquired from a third party specifically for Buyer (a “Special Order Product”), then Buyer agrees that (i) Buyer, at its sole discretion, has made the selection of such Special Order Product, (ii) such Special Order Product is being acquired by MRP solely at the request of Buyer, (iii) no representation, warranty or guarantee has been made by MRP with respect to such Special Order Product, (iv) the obligation of Buyer to pay MRP for the Special Order Product is absolute and unconditional, and (v) Buyer waives and releases MRP from all claims, damages and losses arising out of such Special Order Product. Special Order Products carry no right to inspection before or after delivery, and MRP is not responsible for examining or evaluating such Special Order Products. MRP makes no warranty about Special Order Products and offerings of the third party (including description of the Special Order Product). MRP does not assume any responsibility or liability for the actions, product and content of all these and any other third parties. If there are any problems with any Special Order Product, Buyer must contact the manufacturer of such Special Order Product for assistance.

(c) Limited Warranties, If Any.

(i) If the Quote expressly states that the Equipment has a warranty for a certain time (a “Warranty Period”), then MRP warrants that the Equipment shall be in good working order under normal use for the Warranty Period, which Warranty Period shall commence from the date of delivery to Buyer (the “Delivery Date”), unless otherwise approved by an MRP Officer in writing, except for the following: (A) New (not used or pre-owned) Equipment that is to be serviced by MRP: if the Quote is silent, warranted to be in good working order under normal use for one hundred eighty (180) days from the Delivery Date; (B) Used Equipment sold refurbished by MRP: if the Quote is silent, warranted to be in good working order under normal use for thirty (30) days from the Delivery Date; (C) Consumable/disposable Equipment: if the Quote is silent, warranted to have been shipped from MRP in functional condition, and no additional warranty shall apply; no service shall be provided either. These items should be inspected for obvious damage, subject to Section 6 and 8(e), and MRP’s obligation under this warranty and this Section 8(c)(i)(C) is limited to replacement of the Equipment; and (D) New (not used or pre-owned) Equipment that is to be serviced by the manufacturer: if the Quote is silent, MRP makes no warranty for any such Equipment. Buyer’s sole warranty for any such Equipment, if any, shall be the original manufacturer’s warranty, which MRP agrees to pass on to Buyer, as applicable. (ii) For the limited warranties of Section 8(c)(i), including exceptions (A) and (B), but not (C) or this (D), Buyer is entitled to telephone, e-mail and video technical assistance and, subject to Sections 8(d) and 8(e), repair or replacement of such Equipment, in MRP’s sole discretion, should the Equipment become inoperative through normal use during the Warranty Period. Loaner equipment is not provided, but if so arranged by MRP, Buyer shall pay MRP the cash list price of any unreturned loaner equipment provided by MRP within seven (7) days of a written demand from MRP. (iii) Repair or replacement under any limited warranty of Equipment may be with parts or products that are new, used or refurbished, carrying the same limited warranty for the remaining term of the original item. Repairs or replacements shall not interrupt, extend or prolong the term of the warranty. (iv) For Services purchased under this Agreement, MRP warrants that the Services shall be performed using competent personnel in a professional manner in accordance with generally recognized industry standards for similar services. Subject to Sections 6 and 8(e) herein, if any Service was not performed in accordance with the aforementioned warranty, then MRP shall, in its sole discretion, either (A) repair or re-perform the applicable Service, or (B) credit or refund the price of such Service at the pro rata contract rate.

(d) Exclusions. MRP reserves the right, without liability, to void all warranties and remedies, including any obligation to service, repair, replace or otherwise remedy defects, errors or failures of the Equipment due to the occurrence of any of these events, and MRP shall be in no way responsible for: (i) handling, maintenance or use in a manner that is inconsistent with and/or contrary to the original manufacturer’s or MRP’s recommended procedures and/or instructions, including, without limitation, use of or with an unauthorized third-party good or part; (ii) any failure or damage resulting from negligence, alteration, modification or relocation of the Equipment by Buyer, its employees, agents or representatives; (iii) attempted or actual unauthorized dismantling, disassembling, service, repair, addition or change of the Equipment, including, without limitation, changing the serial number or shot count; (iv) abnormal wear and tear, including, without limitation, use under abnormal conditions (e.g., unclean, dusty, or exposure to extreme electromagnetic radiation, temperature or humidity); or (v) damage or failure of the Equipment due to a Force Majeure Event or a problem in the premises of the Equipment. In any of the above situations, or for any Equipment that has no warranty, MRP has sole discretion to service the Equipment, at Buyer’s expense, at MRP’s then-in-effect rates for service, labor, travel, shipping and materials.

(e) Notice and Inspection. The limited warranties contained in this Section 8 are made on condition that immediate written notice of any noncompliance with the Equipment’s and/or the Service’s warranty be given to MRP, and provided that MRP’s inspection reveals that Buyer’s claim is valid under the terms of such warranty.

        9.  DISCLAIMERS; NO OTHER WARRANTY. EXCEPT TO THE EXTENT AS PROVIDED IN SECTION 8(c)(i)(D), BUYER ACKNOWLEDGES THAT MRP IS NOT BOUND BY ANY WARRANTY THAT MAY BE SET FORTH IN A MANUFACTURER’S WRITTEN MATERIALS THAT WOULD HAVE APPLIED HAD BUYER PURCHASED THE EQUIPMENT DIRECTLY FROM THE MANUFACTURER IN ITS UNUSED STATE. BUYER ACKNOWLEDGES THAT BUYER HAS NOT RELIED UPON ANY WARRANTY OTHER THAN AS SET FORTH IN THIS AGREEMENT. IN ADDITION, BUYER ALSO HEREBY ACKNOWLEDGES AND AGREES THAT ANY ORAL OR WRITTEN STATEMENTS CONCERNING USE AND REGULATION OF MEDICAL DEVICES SOLD BY MRP ARE AND SHALL BE CONSTRUED AS FOR INFORMATIONAL PURPOSES ONLY AND WITHOUT WARRANTY OR ASSURANCE BY MRP AS TO THEIR ACCURACY OR VALIDITY. MRP ALSO HEREBY DISCLAIMS ANY AND ALL WARRANTIES REGARDING OTHER MEDICAL CARE OR HELP, INCLUDING THE SELECTION OF AESTHETIC AND MEDICAL PROCEDURES AND PRODUCTS FOR, OR CARE OF, PATIENTS. THE LIMITED WARRANTIES OF THIS AGREEMENT, IF APPLICABLE TO ANY EQUIPMENT OR SERVICE FURNISHED UNDER THIS AGREEMENT, CONSTITUTE THE ONLY WARRANTIES MADE WITH RESPECT TO THE EQUIPMENT AND/OR SERVICE AND ANY DEFECT, DEFICIENCY OR NONCONFORMITY. TO THE EXTENT PERMITTED BY LAW, SUCH WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY EXPRESS OR IMPLIED WARRANTY OF MERCHANTABILITY, TITLE, NONINFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE.

        10.  LIMITATION OF LIABILITY. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, UNDER NO CIRCUMSTANCES SHALL MRP BE LIABLE FOR ANY INDIRECT, PUNITIVE, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY OR SPECIAL DAMAGES, ARISING FROM, RELATED TO OR CAUSED, DIRECTLY OR INDIRECTLY, WHETHER FORESEEABLE OR NOT, BY THE EQUIPMENT AND/OR THE SERVICES, THE USE OR INABILITY TO USE THE EQUIPMENT, THE RESULTS GENERATED FROM THE EQUIPMENT AND/OR THE SERVICES, THIS AGREEMENT, ANY OTHER ACT OR OMISSION OF MRP, OR BASED UPON ANY OTHER LEGAL THEORY. IN NO EVENT SHALL MRP BE LIABLE FOR ANY LOSSES OF REVENUE, USE, BUSINESS OPPORTUNITY, PROFIT, SAVINGS OR ANY OTHER DAMAGES DUE TO ANY CAUSE WHATSOEVER, EVEN IF MRP OR ITS AGENTS HAS BEEN ADVISED OF THE POSSIBILITY THEREOF. THE FOREGOING IS A SEPARATE, ESSENTIAL TERM OF THIS AGREEMENT, AND SHALL BE EFFECTIVE UPON THE FAILURE OF ANY REMEDY, EXCLUSIVE OR NOT. IN NO EVENT WILL MRP’S TOTAL LIABILITY UNDER THIS AGREEMENT EXCEED THE PURCHASE PRICE ACTUALLY PAID TO MRP BY BUYER FOR THE EQUIPMENT AND/OR THE SERVICES GIVING RISE TO THE CLAIM FOR WHICH DAMAGES ARE BEING SOUGHT. NO SUIT OR ACTION MAY BE BROUGHT BY BUYER, ITS SHAREHOLDERS, DIRECTORS, MANAGERS, EMPLOYEES OR AGENTS FOR ANY BREACH OF THIS AGREEMENT MORE THAN ONE (1) YEAR AFTER THE ACCRUAL OF SUCH CAUSE OF ACTION. IT IS AGREED THAT MRP’S LIABILITY IS SO LIMITED. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, BUYER ASSUMES ALL RISK AND LIABILITY FOR THE RESULTS OBTAINED BY THE USE OF ANY EQUIPMENT IN THE PRACTICE OF ANY PROCESS, WHETHER IN TERMS OF OPERATING COSTS, GENERAL EFFECTIVENESS, SUCCESS OR FAILURE, AND REGARDLESS OF ANY ORAL OR WRITTEN STATEMENTS MADE BY MRP, BY WAY OF TECHNICAL ADVICE OR OTHERWISE, RELATED TO THE USE OF THE EQUIPMENT.

        11.  BUYER’S REPRESENTATIONS AND WARRANTIES. Buyer represents and warrants to MRP that: (a) Buyer is duly organized, validly existing, and in good standing in the jurisdiction of Buyer’s formation; (b) Buyer is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required; (c) Buyer has the full right, power, and authority to enter into this Agreement and to perform Buyer’s obligations under this Agreement; (d) the execution of this Agreement by the person whose signature is set forth at the end hereof has been duly authorized by all necessary corporate action of Buyer; (e) when executed and delivered by each of MRP and Buyer, this Agreement will constitute the legal, valid and binding obligation of Buyer, enforceable against Buyer in accordance with its terms; (f) Buyer is in compliance with all applicable laws relating to this Agreement, the Equipment and the operation of Buyer’s business; (g) Buyer is not insolvent and is paying all of its debts as they become due; and (h) all financial information that Buyer has provided to MRP is true and accurate and fairly represents Buyer’s financial condition.

        12. PROPRIETARY RIGHTS.

(a) Ownership. No sale shall be construed as granting to Buyer any license or other right in, or to, any of MRP’s (i) patents; (ii) trademarks; (iii) internet domain names, whether or not trademarks, registered by any authorized private registrar or governmental authority, web addresses, web pages, websites and URLs; (iv) works of authorship, expressions, designs and design registrations, whether or not copyrightable, including copyrights and copyrightable works, software and firmware, technical data, data files, and databases and other specifications and documentation; (v) trade secrets; (vi) environmental or other testing applicable to the Equipment and/or the Services; and (vii) industrial and other intellectual property rights, and all rights, interests, and protections that are associated with, equivalent or similar to, or required for the exercise of, any of the foregoing, however arising, in each case whether registered or unregistered and including all registrations and applications for, and renewals or extensions of, such rights or forms of protection pursuant to the laws of any jurisdiction throughout in any part of the world (collectively, the “Intellectual Property Rights”).

(b) Prohibited Acts. Buyer shall not (i) take any action that might interfere with any of MRP’s rights in or to Intellectual Property Rights, including MRP’s ownership or exercise thereof; (ii) challenge any right, title, or interest of MRP in or to the Intellectual Property Rights; (iii) make any claim or take any action adverse to MRP’s ownership of the Intellectual Property Rights; (iv) register or apply for registrations, anywhere in the world, for MRP’s trademarks or any other trademark that is similar to MRP’s trademarks or that incorporates MRP’s trademarks in whole or in confusingly similar part; (v) use any mark, anywhere that is confusingly

similar to MRP’s trademarks in whole or in confusingly similar part; (vi) engage in any action that tends to disparage, dilute the value of or reflect negatively on the Equipment and/or the Services or any of MRP’s trademarks; (vii) misappropriate any of MRP’s trademarks for use as a domain name without prior written consent from MRP; or (viii) alter, obscure or remove any of MRP’s trademarks, or trademark or copyright notices or any other proprietary rights notices placed on the

Equipment, marketing materials or other materials that MRP may provide.

        13.  CONFIDENTIAL INFORMATION. Without the prior written consent of MRP,Buyer, directly or indirectly, shall not disclose (and will direct its directors, shareholders, employees and agents not to disclose) any Confidential Information. The term “Confidential Information” means any information of or relating to MRP or the Equipment and/or the Services not generally known to the public (other than as a result of disclosure in violation of this Agreement) in spoken, printed, electronic or any other form or medium, including, but not limited to, business processes, practices, methods, policies, plans, publications, documents, research, operations, services, strategies, techniques, agreements, contracts, transactions, potential transactions, know-how, trade secrets, databases, manuals, records, supplier information, financial information, accounting information, legal information, marketing information, pricing information, payroll information, personnel information, and supplier lists.

        14.  NON-SOLICITATION. Buyer agrees not to solicit or hire any personnel of MRP involved with the delivery of the Services during the provision of such Services and for twelve (12) months after the completion of such Services; provided, however, that Buyer may hire individuals employed by MRP who, without other solicitation, respond to advertisements or solicitations aimed at the general public.

        15.  EQUITABLE REMEDIES. Buyer acknowledges and agrees that (a) a breach or threatened breach by Buyer of any of its obligations under Sections 13 or 14 would give rise to irreparable harm to MRP for which monetary damages would not be an adequate remedy and (b) in the event of a breach or a threatened breach by Buyer of any such obligations, MRP shall, in addition to any and all other rights and remedies that may be available to MRP at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance, and any other relief that may be available from a court of competent jurisdiction, without any requirement to post a bond or other security, and without any requirement to prove actual damages or that monetary damages will not afford an adequate remedy. Buyer agrees that Buyer will not oppose or otherwise challenge the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this Section 15.

        16.  INDEMNIFICATION. Buyer agrees to indemnify, defend and hold harmless MRP and its directors, shareholders, employees and agents (collectively, “MRP Indemnitees”) against any liability, damage, loss or expense incurred by or imposed in connection with any claims, suits, actions, demands or judgments arising out of (a) any breach or non-fulfillment of any representation, warranty or covenant set forth in this Agreement by Buyer or its directors, managers, employees or agents (collectively, “Buyer’s Agents”); (b) any negligent act or omission or willful misconduct of Buyer or Buyer’s Agents in connection with this Agreement; (c) any bodily injury, death of any person or damage to real or tangible personal property caused by Buyer or Buyer’s Agents, including the use of unauthorized parts in or service of the Equipment; (d) any failure by Buyer or Buyer’s Agents to comply with any applicable laws; (e) any fraud or other intentional acts by Buyer or Buyer’s Agents; and (f) the use or operation of the Equipment, including, without limitation, any medical and/or surgical procedures performed by Buyer, and any of Buyer’s Agents, using the Equipment unless said damages are determined by a court of competence jurisdiction to be solely by the gross negligence of MRP or solely as result of a breach by MRP of the limited warranties contained herein.

        17.  DEFAULTS; REMEDIES. Notwithstanding anything herein to the contrary, should Buyer fail to pay for the order or any other amount, in whole or in part, when due or perform its other obligations under this Agreement or as otherwise mutually agreed in writing between Buyer and MRP (each, a “Default”), then MRP may take any and all actions available under law or equity to collect said amounts with a ten (10) day prior written notice, including, but not limited to, enforcing its security interest, accelerating the payment of and declaring immediately due and payable any unpaid balance of the order, referral to outside collection agencies and/or commencement of legal action. MRP’s rights shall be cumulative, and it shall not be required to have attempted to realize upon to the Equipment before taking any other collection actions. MRP may require that Buyer assemble and return any or all of the Equipment to MRP and, in the event Buyer fails to return such Equipment peaceably, enter upon the premises where such Equipment is located, with or without legal process, and repossess such Equipment. Upon a Default, Buyer agrees to pay upon MRP’s demand: (i) all costs and expenses incurred by MRP or its assignee in connection with the enforcement of any remedies, including all expenses incurred in connection with the return, sale, release or other disposition of the Equipment, including attorneys’ fees and other costs incurred by MRP or its assignee in enforcing or defending its rights and remedies under this Agreement and any other written agreement between Buyer and MRP.

        18.  COMPLIANCE WITH LAWS. Buyer shall (a) carry out the transactions contemplated by this sale and deal with the Equipment in conformity with all applicable laws, rules and regulations of all government authorities, including, without limitation, export laws, (b) obtain all permits and licenses required in connection with the purchase, shipment, installation or use of the Equipment, and (c) be solely responsible to fully understand and comply with laws, rules and regulations. Any information provided is as a convenience only.

        19.  FURTHER ASSURANCES. Upon MRP’s reasonable request, Buyer shall, at its sole cost and expense, execute and deliver all such further documents and instruments, and take all such further acts, necessary to give full effect to this Agreement.

        20.  ASSIGNMENT; SUCCESSORS AND ASSIGNS. Buyer cannot delegate any duties nor assign any rights or claims under this Agreement without MRP’s prior written consent, and any such attempt or assignment shall be void. In the event that Buyer finances its acquisition of any Equipment with a third party, Buyer may direct MRP to transfer title of such Equipment to such third-party financing company, with all remaining terms and conditions of this Agreement remaining in full force and effect. This Agreement is binding on and inures to the benefit of the parties to this Agreement and their respective permitted successors and permitted assigns.

        21.  NO THIRD-PARTY BENEFICIARIES. Subject to Section 16, this Agreement benefits solely the parties to this Agreement and their respective permitted successors and assigns, and nothing in this Agreement, express or implied, confers on any other person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

        22.  GOVERNING LAW; VENUE. The application of the UN Convention on Contracts for the International Sale of Goods is expressly excluded. The parties agree that any and all claims, demands, disagreements, controversies or disputes arising out of or relating to this Agreement and any agreement or document delivered in connection herewith (collectively, “Claims”) shall be governed by and construed in accordance with the laws of the State of Utah and adjudicated exclusively in the state and federal courts located in or nearest to Summit County, Utah, which courts shall have the sole and exclusive jurisdiction and venue for adjudication of all Claims. The parties hereby agree upon, consent and stipulate to the jurisdiction and venue of the aforementioned courts for the adjudication of all Claims, to the exclusion of all other courts, forums and venues whatsoever.

        23.  NON-DISPARAGEMENT. Buyer shall not disparage MRP or MRP’s trademarks, websites, products or services, or display any such items in a derogatory or negative manner on any website or in any public forum or press release.

        24.  NOTICES. Any notice, demand, or communication required, permitted or desired to be given hereunder shall be deemed effectively given when personally delivered, when sent by electronic means, when received by overnight courier, or when mailed by prepaid, certified or registered mail, return receipt requested, addressed to the other party at its address set forth on the Quote or to such other address that the receiving party may designate from time to time in accordance with this Section 25.

        25.  PUBLIC ANNOUNCEMENTS. Unless otherwise stated herein, neither party shall issue a press release or otherwise advertise, make a public statement or disclose to any third-party information pertaining to the relationship arising under this Agreement, the existence or terms of this Agreement, the underlying transactions between MRP and Buyer or agent for Buyer or refer to the other party in relation to this Agreement without the other party’s prior written approval.

        26.  ENTIRE AGREEMENT; ADDITIONAL OR INCONSISTENT TERMS. Subject to Section 32, this Agreement constitutes the sole and entire agreement between the parties hereto relating to the subject matter hereof, and any unincorporated representation, affirmation of fact, course of prior dealings, promise or condition in connection therewith, or usage of the trade, shall not be binding on either party. Terms and conditions set forth which differ from, conflict with or are not included in this Agreement shall not be part of any agreement between MRP and Buyer unless both parties specifically accept such terms and conditions in writing.

        27.  WAIVER. No waiver under this Agreement is effective unless it is in writing and signed by the party waiving its right. Any waiver authorized on one occasion is effective only in that instance and only for the purpose stated and does not operate as a waiver on any future occasion. None of the following constitutes a waiver or estoppel of any right, remedy, power, privilege or condition arising from this Agreement: any failure or delay in exercising any right, remedy, power or privilege or in enforcing any condition under this Agreement; or any act, omission or course of dealing between the parties.

        28.  SURVIVAL. Subject to the limitations and other provisions of this Agreement, the representations and warranties of Buyer contained herein shall survive the expiration or earlier termination of this Agreement for a period of twelve (12) months after such expiration o termination and (b) this Section 29 and Sections 10, 12, 13, 14, 15, 16, 17, 21, 22, 23, 24, 26, and 32 of this Agreement, as well as any other provision that, in order to give proper effect to its intent, should survive such expiration or termination, shall survive the expiration or earlier termination of this Agreement. All other provisions of this Agreement shall not survive the expiration or earlier termination of this Agreement.

        29.  RELATIONSHIP OF PARTIES. Nothing in this Agreement creates any agency, joint venture, partnership or other form of joint enterprise, employment or fiduciary relationship between the parties. Neither party has any express or implied right or authority to assume or create any obligations on behalf of or in the name of the other party or to bind the other party to any contract, agreement or undertaking with any third party.

        30.  HEADINGS. The headings in this Agreement are for reference only and do not affect the interpretation of this Agreement.

        31.  ORDER OF PRECEDENCE. In the event of conflict between the Quote, a written agreement by MRP, and these Terms, the order of priority shall be: (1) the written

agreement by MRP, if only if executed by an MRP Officer, (2) the Quote and (3) these Terms, and only to the extent of the direct conflict. Notwithstanding the foregoing, MRP shall not be bound by, and specifically objects to, any terms, conditions or other provisions, both written and oral, which are different from, in addition to or inconsistent with the provisions of this Agreement which are set forth in any purchase order, receipt, acceptance, confirmation, correspondence or otherwise of, or by, Buyer. Fulfillment of Buyer’s order shall not constitute acceptance of any of Buyer’s terms and conditions and does not serve to modify or amend the terms and conditions contained herein.

        32.  SEVERABILITY. If any part of this Agreement is held to be void, illegal or unenforceable, then it shall be deemed to be severed from this Agreement and the remaining provisions shall continue in full force and effect; provided, however, that if any fundamental term or provision of this Agreement is held to be void, illegal or unenforceable, the remainder of this Agreement shall be unenforceable. Upon a determination that any term or provision is void, illegal or unenforceable, the parties shall negotiate in good faith to modify this Agreement to effect the original intent of the parties as closely as possible in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.